Cynthia M. Butitta, Chief Operating Officer at Kite Pharma, Inc. (KITE), sold 8,456 shares at $179.66 ($1.5M) on 2017-09-25, disclosed to the SEC on 2017-09-27.
Open-market sale of $1.5M KITE by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $179.66 | 4,228 | $760K | 50.0% |
| 2 | $179.66 | 4,228 | $760K | 50.0% |
| Total | $179.66 avg | 8,456 | $1.5M | 100% |
| Filing → |
| KITE | SELL | 2017-06-27 | $711K | — | Filing → |
| KITE | SELL | 2017-06-12 | $885K | — | Filing → |
| KITE | SELL | 2017-04-27 | $2.5M | — | Filing → |